| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/29/2010 | CA2750321A1 Stable vaccine compositions and methods of use |
| 07/29/2010 | CA2749213A1 Mycoplasma gallisepticum formulation |
| 07/29/2010 | CA2749055A1 Antiviral agents |
| 07/29/2010 | CA2748942A1 Pharmaceutical composition for preventing or treating hepatitis c, comprising the roots extract of platycodon grandiflorum or platycodon grandiflorum saponin components |
| 07/29/2010 | CA2747801A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity |
| 07/28/2010 | EP2210945A2 Neisseria meningitidis antigens |
| 07/28/2010 | EP2210893A1 Polymorphous forms of rifaximin as antibiotics |
| 07/28/2010 | EP2210603A1 Pharmaceutical composition for inhibiting the accumulation of amyloid- b protein |
| 07/28/2010 | EP2209810A1 Viral therapeutic |
| 07/28/2010 | EP2209789A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 07/28/2010 | EP2209470A1 Pharmaceutical composition comprising peroxided oil and cholesterol and uses thereof in medical field |
| 07/28/2010 | EP1776387B1 Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2 |
| 07/28/2010 | EP1458392B9 Acridones as inhibitors of impdh enzyme |
| 07/28/2010 | CN1974596B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 07/28/2010 | CN1905875B The use of quaternary pyridinium salts as vasoprotective agents |
| 07/28/2010 | CN1788000B Phthalazinone derivatives |
| 07/28/2010 | CN1767819B Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol |
| 07/28/2010 | CN1651457B Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens |
| 07/28/2010 | CN1625409B Immunogen preparation of variable peptidic epitopes and preparation method thereof |
| 07/28/2010 | CN101790687A Use of procalcitonin (pct) in risk stratification and prognosis of patients with a primary, non-infectious disease |
| 07/28/2010 | CN101790540A Local administration of chicken yolk immune globulins (igy) to treat and prevent fungal infections |
| 07/28/2010 | CN101790533A cyclopropyl fused indolobenzazepine hcv inhibitors |
| 07/28/2010 | CN101790371A Combination formulations comprising darunavir and etravirine |
| 07/28/2010 | CN101787371A Chemosynthetic HSV2 virus gD glycoprotein extracellular region gene segment as well as expression and application thereof |
| 07/28/2010 | CN101787116A Compound and application thereof in preparing drug for curing viral respiratory infection |
| 07/28/2010 | CN101787079A High-purity horse anti-rabies virus antibody F(ab')2 fragment |
| 07/28/2010 | CN101787063A Anti-infective medicament and preparation and application thereof |
| 07/28/2010 | CN101787030A Preparation and application methods of anti-HIV compound, morus ignin L |
| 07/28/2010 | CN101787026A Amorphous entecavir p-toluenesulfonate salt and preparation method and medicament application thereof |
| 07/28/2010 | CN101787025A Substituted-evodiamine anti-tumor and antifungal compounds and preparation method thereof |
| 07/28/2010 | CN101787022A Quinoline carboxylic acid hydrochloride-hydrate novel crystal form, preparation method and application thereof |
| 07/28/2010 | CN101787008A N-acetyl neuraminic acid compounds, medicine compositions thereof and preparation methods and purposes thereof |
| 07/28/2010 | CN101787007A Dimeric sesquiterpene compound and applications thereof |
| 07/28/2010 | CN101787004A Lignanoid compound contained in Yunnan daphne herb, as well as preparation method and application thereof |
| 07/28/2010 | CN101786979A (+/-)-marinopyrrole A for resisting methicillin-resistant staphylococcus aureus (MRSA) and synthesized derivative thereof |
| 07/28/2010 | CN101785861A Injectable compositions for the controlled delivery of pharmacologically active compound |
| 07/28/2010 | CN101785857A Novel pneumococcal conjugate vaccine and preparation method thereof |
| 07/28/2010 | CN101785841A External preparation for children angina parotidea treatment |
| 07/28/2010 | CN101785837A Traditional Chinese medicine lotion for tinea manus and pedis treatment |
| 07/28/2010 | CN101785836A Traditional Chinese medicine ointment, preparation method and application thereof for skin disease treatment |
| 07/28/2010 | CN101785832A Traditional Chinese medicine preparation and preparation method thereof for skin disease treatment |
| 07/28/2010 | CN101785830A Antibacterial agent and antibacterial composition |
| 07/28/2010 | CN101785799A Extract of total triterpenes in dracocephalum moldavica and preparation method and application thereof |
| 07/28/2010 | CN101785796A Method for preparing Jingan capsules |
| 07/28/2010 | CN101785795A Preparation method of Tibetan capillaris tablet |
| 07/28/2010 | CN101785786A Chlorine dioxide ointment used for treating dermatophytosis |
| 07/28/2010 | CN101785783A Use of metal Ti microparticles in promotion or increase of potency of externally-applied skin antibacterial or sterilizing medicaments |
| 07/28/2010 | CN101785779A Separation and preparation of isovaleryl-spiramycin II and application thereof |
| 07/28/2010 | CN101785778A Separation and preparation of isovaleryl-spiramycin I and application thereof |
| 07/28/2010 | CN101785771A Compound isoniazid tablet |
| 07/28/2010 | CN101785768A Bactericide for rabbits |
| 07/28/2010 | CN101785758A Cefmenoxime hydrochloride/anhydrous sodium carbonate pharmaceutical composition liposome injection |
| 07/28/2010 | CN101785756A Celtezole sodium suspension preparation and novel application thereof |
| 07/28/2010 | CN101785755A Antofloxacin hydrochlorid injection and preparation method and purpose thereof |
| 07/28/2010 | CN101785749A Sterilizing skin moistening liquid soap |
| 07/28/2010 | CN101785477A Polyoxyethylene nonyl phenyl ether iodine complex disinfecting solution and preparation method thereof |
| 07/28/2010 | CN101461805B Use of anti-hantavirus medicament arbidol |
| 07/28/2010 | CN101380326B Gluconic acid enoxacin and powder injection preparation method |
| 07/28/2010 | CN101279979B Separation and purification method of cefamandole nafate and preparation of cefathiamidine freeze-dried injectable powder |
| 07/28/2010 | CN101185650B Penciclovir ophthalmic temperature sensitivity in situ gel preparation and preparation method thereof |
| 07/28/2010 | CN101019913B Externally applied medicine for treating herpes zoster |
| 07/27/2010 | US7763729 Bicyclic heteroaromatic derivatives |
| 07/27/2010 | US7763718 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 07/27/2010 | US7763705 Viral peptides for use in activating immune response to treat and prevent viral infection |
| 07/27/2010 | US7763704 Chemically synthesized S3 peptide from Sushi3 domain of Factor C; endotoxin-sensitive serine protease binds, neutralizes lipopolysaccharide activity; Fluorescent tagged-S3 detects LPS-containing bacteria; pathogen-recognizing molecules, tandem multimers of the S3 gene constructed and expressed in E. coli |
| 07/27/2010 | US7763660 administering 1-(5-methyl-2-propan-2-ylcyclohexyl)oxy-3-piperidin-1-ylpropan-2-ol, for the treatment fungal infection in humans and mammals; inhibitors of the budded-to-hyphal transition of yeasts |
| 07/27/2010 | US7763641 such as [(1S,2R)-2-hydroxy-3-[N-[4-(2-methylaminothiazol-4-yl)phenylsulfonyl]-N-(2-methylpropyl)amino]-1-(phenylmethyl)propyl]carbamic acid, [(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl]ester, used for treating human immunodeficiency virus infections |
| 07/27/2010 | US7763631 substituted amino pyrimidine derivatives useful in the treatment or prevention of viral infections, in particular against human immunodeficiency virus (HIV), which is the aetiological agent of acquired immune deficiency syndrome (AIDS) in humans |
| 07/27/2010 | US7763616 Chemokine receptor antagonists, used for the treatment of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, hypersensitivity responses, ophthalmic inflammation, diabetes, viral meningitis and tumors |
| 07/27/2010 | US7763602 Drug resistant Mycobacterium tuberculosis |
| 07/27/2010 | US7763597 Salts |
| 07/27/2010 | US7763589 Administering a vector construct that expresses an immunogenic portion of an antigen derived from a pathogen, and administering an immunogenic protein of said antigen, to generate an immune response |
| 07/27/2010 | US7763435 Method for diagnosis of alzheimer's disease with determination of LASP-1 immunoreactivity |
| 07/27/2010 | US7763262 Attenuated yiaO mutants of Pasteurellaceae bacteria |
| 07/27/2010 | CA2470105C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents |
| 07/27/2010 | CA2463084C Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity |
| 07/27/2010 | CA2449031C Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 07/27/2010 | CA2436659C Cannabinoid receptor ligands |
| 07/27/2010 | CA2384717C Topical treatment for prevention of ocular infections |
| 07/27/2010 | CA2375820C The myostatin gene promoter and inhibition of activation thereof |
| 07/27/2010 | CA2332829C Vaccine delivery system |
| 07/27/2010 | CA2264810C Method of producing active immunity with vaccine conjugate |
| 07/22/2010 | WO2010083504A2 Therapeutic charge engineered variants of lysozyme and methods for using same to treat infections |
| 07/22/2010 | WO2010083477A2 Broad spectrum vaccine against non-typhoidal salmonella |
| 07/22/2010 | WO2010083436A1 Benzo [c] phenanthridines as antimicrobial agents |
| 07/22/2010 | WO2010082726A2 Process for purifying vancomycin wet body |
| 07/22/2010 | WO2010082182A1 Fulvic acid in combination with fluconazole or amphotericin b for the treatment of fungal infections |
| 07/22/2010 | WO2010082134A1 Combination antibodies for the treatment and prevention of disease caused by bacillus anthracis and related bacteria and their toxins |
| 07/22/2010 | WO2010082050A1 Macrocyclic and 7-aminoalkyl-substituted benzoxazocines for treatment of hepatitis c infections |
| 07/22/2010 | WO2010082020A1 Vaccine |
| 07/22/2010 | WO2010081856A1 Pulmonary administration of immunoglobulin single variable domains and constructs thereof |
| 07/22/2010 | WO2010081851A1 Piperidin-4-ylpiperazine compounds for the treatment of hcv infection |
| 07/22/2010 | WO2010081849A1 Agent for preventing and treating pityriasis versicolor |
| 07/22/2010 | WO2010081387A1 N-substituted phenyl-3-methylene heterocyclic aryl-2,5-dimethylpyrrole compounds and anti-hiv/aids uses thereof |
| 07/22/2010 | WO2010081341A1 The crystal form i of n-n-propyl-3-(4-methylphenyl) -4-(methylsulfonylphenyl)-2,5-dihydropyrrole-2-one and the preparation method thereof |
| 07/22/2010 | WO2010081257A1 Composition comprising bacillus calmette guerin polysaccharides and bacillus calmette guerin nucleic acids and use of preparing medicament thereof |
| 07/22/2010 | WO2010056978A3 System and method for controlling growth of microganisms with brominated furanones |
| 07/22/2010 | WO2010046572A3 Anti-influenza device and composition containing extracts from olive tree leaves, grapefruit pips, rosemary, green tea and curcumin |
| 07/22/2010 | WO2010032011A3 Anti-fungal therapy |
| 07/22/2010 | WO2010030666A3 Elimination of a contaminating non-human sialic acid by metabolic competition |